CHAM
Clear Harbor Asset Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Sell |
122,894
-290
| -0.2% | -$360 | 0.01% | 384 |
|
|
2025
Q1 | $145K | Buy |
123,184
+9,298
| +8% | +$11K | 0.01% | 377 |
|
|
2024
Q4 | $208K | Sell |
113,886
-6,000
| -5% | -$11K | 0.02% | 339 |
|
|
2024
Q3 | $204K | Sell |
119,886
-50
| -0% | -$85 | 0.02% | 327 |
|
|
2024
Q2 | $164K | Buy |
119,936
+5,000
| +4% | +$6.85K | 0.01% | 330 |
|
|
2024
Q1 | $431K | Buy |
114,936
+50,886
| +79% | +$191K | 0.04% | 237 |
|
|
2023
Q4 | $628K | Buy |
64,050
+7,400
| +13% | +$72.6K | 0.06% | 188 |
|
|
2023
Q3 | $473K | Sell |
56,650
-600
| -1% | -$5.01K | 0.05% | 210 |
|
|
2023
Q2 | $761K | Buy |
57,250
+36
| +0.1% | +$479 | 0.07% | 171 |
|
|
2023
Q1 | $663K | Buy |
57,214
+3,662
| +7% | +$42.4K | 0.07% | 196 |
|
|
2022
Q4 | $438K | Buy |
53,552
+3,802
| +8% | +$31.1K | 0.05% | 222 |
|
|
2022
Q3 | $289K | Hold |
49,750
| – | – | 0.04% | 261 |
|
|
2022
Q2 | $220K | Buy |
+49,750
| New | +$220K | 0.03% | 311 |
|
|
2020
Q4 | – | Sell |
-5,500
| Closed | -$54.3K | – | 600 |
|
|
2020
Q3 | $54.3K | Buy |
+5,500
| New | +$54.3K | 0.01% | 382 |
|